Home / Inspections / 1215614

FDA Inspection 1215614 — Montefiore's Institute for Reproductive Medicine and Health

Montefiore's Institute for Reproductive Medicine and Health — FEI 3003972343

The FDA completed an inspection of Montefiore's Institute for Reproductive Medicine and Health on August 16, 2023 in Hartsdale, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Hartsdale, NY (United States)

Facility

Other inspections at this facility

  • 1327662 (NAI Wed Jun 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1148967 (VAI Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1088610 (NAI Fri May 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008038 (NAI Wed Mar 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938861 (VAI Mon Aug 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources